EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CASynergy: A causal attention model for interpretable prediction of cancer drug synergy

Haitao Li iD, Long Zheng, Lei Li, Yiwei Chen, Junjie Li, Chunhou Zheng, Yansen Su iD

PLOS Computational Biology · 2025

DOI: 10.1371/journal.pcbi.1013567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Haitao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Intelligent Computing & Signal Processing, School of Artificial Intelligence, Anhui University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Neoplasms, Drug Synergism, Antineoplastic Agents. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University Synergy Innovation Program of Anhui Prov-ince, National Natural Science Foundation of China, Anhui Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer drug combination therapies offer a promising strategy to overcome resistance and improve treatment efficacy, but identifying synergistic drug pairs is challenging due to complex biological interactions and tumor heterogeneity. Current machine learning algorithms for drug synergy prediction primarily rely on large-scale, multimodal datasets, yet suffer from critical limitations including poor interpretability, difficulty distinguishing causative biological relationships from correlations, and inadequate modeling of cancer-specific molecular interactions. To address these challenges, we propose CASynergy (Causal Attention and Cross-attention Synergy), a novel deep learning model for predicting cancer drug synergy that addresses limitations of prior approaches in accuracy and interpretability. CASynergy introduces a causal attention mechanism to distinguish true causal genomic features from spurious correlations, cell line-specific gene network construction to capture the unique molecular context of each cancer cell line, and a cross-attention module to integrate drug molecular features with cell line gene expression profiles. These improvements allow CASynergy to clearly identify significant drug-gene interactions and provides interpretable insights into why a combination is predicted to be synergistic. Experiments on two benchmark datasets (DrugCombDB and Oncology-Screen) suggests that CASynergy outperformed five state-of-the-art models. CASynergy offers a better and more reliable way to predict effective drug combinations. It works well across different cancer types and is easier to understand, which is important for personalized cancer treatment and finding new drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDrug SynergismAntineoplastic AgentsHumansComputational BiologyAlgorithmsCell Line, TumorDeep LearningGene Regulatory Networks

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Intelligent Computing & Signal Processing, School of Artificial Intelligence, Anhui University, Hefei, Anhui, China.
  • Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, Anhui, China.
  • School of Internet, Anhui University, Hefei, China.

ORCID-Profile: Haitao Li, Yansen Su

Förderung

  • The University Synergy Innovation Program of Anhui Prov-ince
  • National Natural Science Foundation of China
  • Anhui Provincial Natural Science Foundation
  • The University Outstanding Youth Re-search Project of Anhui Province
  • The University Synergy Innovation Program of Anhui Province
  • Science Fund for Distinguished Young Scholars of Anhui Province
  • The University Outstanding Youth Research Project of Anhui Province
  • The Project of Key Laboratory of Intelligent Computing & Signal Processing (Anhui University), Ministry of Education

Zitieren

APA

Li, H., Zheng, L., Li, L., Chen, Y., Li, J., Zheng, C., & Su, Y. (2025). CASynergy: A causal attention model for interpretable prediction of cancer drug synergy. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1013567

Vancouver

Li H, Zheng L, Li L, Chen Y, Li J, Zheng C, et al. CASynergy: A causal attention model for interpretable prediction of cancer drug synergy. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1013567

BibTeX
@article{Li2025,
  author = {Li, Haitao and Zheng, Long and Li, Lei and Chen, Yiwei and Li, Junjie and Zheng, Chunhou and Su, Yansen},
  title = {CASynergy: A causal attention model for interpretable prediction of cancer drug synergy},
  journal = {PLOS Computational Biology},
  year = {2025},
  doi = {10.1371/journal.pcbi.1013567}
}
Kostenlos starten →